107 related articles for article (PubMed ID: 18492758)
1. Calorie restriction modulates inactivity-induced changes in the inflammatory markers C-reactive protein and pentraxin-3.
Bosutti A; Malaponte G; Zanetti M; Castellino P; Heer M; Guarnieri G; Biolo G
J Clin Endocrinol Metab; 2008 Aug; 93(8):3226-9. PubMed ID: 18492758
[TBL] [Abstract][Full Text] [Related]
2. The impact of obesity on pentraxin 3 and inflammatory milieu to acute aerobic exercise.
Slusher AL; Mock JT; Whitehurst M; Maharaj A; Huang CJ
Metabolism; 2015 Feb; 64(2):323-9. PubMed ID: 25467846
[TBL] [Abstract][Full Text] [Related]
3. Long pentraxin 3: a marker of inflammation in untreated psoriatic patients.
Bevelacqua V; Libra M; Mazzarino MC; Gangemi P; Nicotra G; Curatolo S; Massimino D; Plumari A; Merito P; Valente G; Stivala F; La Greca S; Malaponte G
Int J Mol Med; 2006 Sep; 18(3):415-23. PubMed ID: 16865225
[TBL] [Abstract][Full Text] [Related]
4. Gastric bypass-induced weight loss alters obesity-associated patterns of plasma pentraxin-3 and systemic inflammatory markers.
Barazzoni R; Palmisano S; Gortan Cappellari G; Giuricin M; Moretti E; Vinci P; Semolic A; Guarnieri G; Zanetti M; Manzini Nd
Surg Obes Relat Dis; 2016 Jan; 12(1):23-32. PubMed ID: 26277450
[TBL] [Abstract][Full Text] [Related]
5. Inverse relationship between the inflammatory marker pentraxin-3, fat body mass, and abdominal obesity in end-stage renal disease.
Miyamoto T; Rashid Qureshi A; Heimbürger O; Bárány P; Carrero K; Sjöberg B; Lindholm B; Stenvinkel P; Carrero JJ
Clin J Am Soc Nephrol; 2011 Dec; 6(12):2785-91. PubMed ID: 22157708
[TBL] [Abstract][Full Text] [Related]
6. Reciprocal contribution of pentraxin 3 and C-reactive protein to obesity and metabolic syndrome.
Ogawa T; Kawano Y; Imamura T; Kawakita K; Sagara M; Matsuo T; Kakitsubata Y; Ishikawa T; Kitamura K; Hatakeyama K; Asada Y; Kodama T
Obesity (Silver Spring); 2010 Sep; 18(9):1871-4. PubMed ID: 20111016
[TBL] [Abstract][Full Text] [Related]
7. Levels of pentraxin-3 in gingival crevicular fluid and plasma in periodontal health and disease.
Pradeep AR; Kathariya R; Raghavendra NM; Sharma A
J Periodontol; 2011 May; 82(5):734-41. PubMed ID: 21080790
[TBL] [Abstract][Full Text] [Related]
8. Plasma pentraxin 3 is associated with cardiovascular disease in hemodialysis patients.
Xu Y; Ding X; Zou J; Liu Z; Jiang S; Xu S; Shen B; Chen Y; Shan Y; Cao X
Ren Fail; 2011; 33(10):998-1004. PubMed ID: 22013933
[TBL] [Abstract][Full Text] [Related]
9. Plasma long pentraxin 3 (PTX3) concentration is a novel marker of disease activity in patients with community-acquired pneumonia.
Kao SJ; Yang HW; Tsao SM; Cheng CW; Bien MY; Yu MC; Bai KJ; Yang SF; Chien MH
Clin Chem Lab Med; 2013 Apr; 51(4):907-13. PubMed ID: 23152412
[TBL] [Abstract][Full Text] [Related]
10. Increased interleukin-6 and high-sensitivity C-reactive protein levels in pediatric epilepsy patients with frequent, refractory generalized motor seizures.
Ishikawa N; Kobayashi Y; Fujii Y; Kobayashi M
Seizure; 2015 Feb; 25():136-40. PubMed ID: 25455727
[TBL] [Abstract][Full Text] [Related]
11. Plasma Pentraxin 3, but not high-sensitivity C-reactive protein, is a useful inflammatory biomarker for predicting cognitive impairment in elderly hypertensive patients.
Yano Y; Matsuda S; Hatakeyama K; Sato Y; Imamura T; Shimada K; Kodama T; Kario K; Asada Y
J Gerontol A Biol Sci Med Sci; 2010 May; 65(5):547-52. PubMed ID: 20203097
[TBL] [Abstract][Full Text] [Related]
12. The energy balance positively regulates the levels of circulating TNF-related apoptosis inducing ligand in humans.
Biolo G; Secchiero P; De Giorgi S; Tisato V; Zauli G
Clin Nutr; 2012 Dec; 31(6):1018-21. PubMed ID: 22633079
[TBL] [Abstract][Full Text] [Related]
13. Saliva and serum levels of pentraxin-3 and interleukin-1β in generalized aggressive or chronic periodontitis.
Gümüş P; Nizam N; Nalbantsoy A; Özçaka Ö; Buduneli N
J Periodontol; 2014 Mar; 85(3):e40-6. PubMed ID: 23952075
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction.
Latini R; Maggioni AP; Peri G; Gonzini L; Lucci D; Mocarelli P; Vago L; Pasqualini F; Signorini S; Soldateschi D; Tarli L; Schweiger C; Fresco C; Cecere R; Tognoni G; Mantovani A;
Circulation; 2004 Oct; 110(16):2349-54. PubMed ID: 15477419
[TBL] [Abstract][Full Text] [Related]
15. Elevated pentraxin-3 levels are related to blood pressure levels in hypertensive patients: an observational study.
Parlak A; Aydoğan U; Iyisoy A; Dikililer MA; Kut A; Cakır E; Sağlam K
Anadolu Kardiyol Derg; 2012 Jun; 12(4):298-304. PubMed ID: 22466361
[TBL] [Abstract][Full Text] [Related]
16. Effect of diet-induced energy deficit and body fat reduction on high-sensitive CRP and other inflammatory markers in obese subjects.
Belza A; Toubro S; Stender S; Astrup A
Int J Obes (Lond); 2009 Apr; 33(4):456-64. PubMed ID: 19238154
[TBL] [Abstract][Full Text] [Related]
17. Effects of physiological leptin administration on markers of inflammation, platelet activation, and platelet aggregation during caloric deprivation.
Canavan B; Salem RO; Schurgin S; Koutkia P; Lipinska I; Laposata M; Grinspoon S
J Clin Endocrinol Metab; 2005 Oct; 90(10):5779-85. PubMed ID: 16076944
[TBL] [Abstract][Full Text] [Related]
18. Subcutaneous adipose tissue cytokine production is not responsible for the restoration of systemic inflammation markers during weight loss.
Salas-Salvadó J; Bulló M; García-Lorda P; Figueredo R; Del Castillo D; Bonada A; Balanzà R
Int J Obes (Lond); 2006 Dec; 30(12):1714-20. PubMed ID: 16652132
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of pentraxin 3 in patients with chronic heart failure.
Kotooka N; Inoue T; Aoki S; Anan M; Komoda H; Node K
Int J Cardiol; 2008 Oct; 130(1):19-22. PubMed ID: 18045709
[TBL] [Abstract][Full Text] [Related]
20. Pentraxin 3 and C-reactive protein in severe meningococcal disease.
Sprong T; Peri G; Neeleman C; Mantovani A; Signorini S; van der Meer JW; van Deuren M
Shock; 2009 Jan; 31(1):28-32. PubMed ID: 18650775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
